Steven James is the founder of Pionyr Immunotherapeutics. Pionyr Immunotherapeutics has raised $78M in total funding. Latest round: Series B.
Steven James is the CEO of Pionyr Immunotherapeutics, a San Francisco-based immuno-oncology company founded in 2015. The company develops antibody-based therapeutics targeting tumor-associated macrophages. He participated as an individual investor in the company's Series A and A-1 financing rounds.
Full founder directory · Investor directory · Company funding database · Fundraising library